

Author: Laframboise S. Milosevic M. Leyland N.
Publisher: Elsevier
ISSN: 0090-8258
Source: Gynecologic Oncology, Vol.75, Iss.1, 1999-10, pp. : 149-151
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content


High-Dose-Rate Brachytherapy for Medically Inoperable Stage I Endometrial Cancer
Gynecologic Oncology, Vol. 71, Iss. 2, 1998-11 ,pp. :








By Han I. Malviya V. Chuba P. Orton C. devi S. deppe G. Malone Sr J. Christensen C. Ahmad K. Kim Y. Porter A.
Gynecologic Oncology, Vol. 63, Iss. 1, 1996-10 ,pp. :